氢氧化铝吸附白喉、破伤风和百日咳联合疫苗用于婴儿免疫接种的优势。
Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants.
作者信息
Butler N R, Voyce M A, Burland W L, Hilton M L
出版信息
Br Med J. 1969 Mar 15;1(5645):663-6. doi: 10.1136/bmj.1.5645.663.
Abstract
Three combined triple antigen vaccines were used to inoculate infants receiving primary immunization at 3 to 6 months of age. Laboratory potency and toxicity tests and clinical evaluation again showed that the mouse weight gain test is able to predict which vaccines will give reactions in children. The addition of aluminium hydroxide to the vaccine both increased potency and reduced the tendency to cause reactions. Assays on sera showed that almost all children produced agglutinins to Bordetella pertussis types 1, 2, and 3 when the vaccine contained aluminium hydroxide.
摘要
使用三种联合三联疫苗对3至6个月大接受初次免疫的婴儿进行接种。实验室效价和毒性测试以及临床评估再次表明，小鼠体重增加试验能够预测哪些疫苗会在儿童中引起反应。在疫苗中添加氢氧化铝既提高了效价又降低了引起反应的倾向。血清检测表明，当疫苗含有氢氧化铝时，几乎所有儿童都产生了针对百日咳博德特氏菌1型、2型和3型的凝集素。
相似文献
1
Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants.氢氧化铝吸附白喉、破伤风和百日咳联合疫苗用于婴儿免疫接种的优势。
Br Med J. 1969 Mar 15;1(5645):663-6. doi: 10.1136/bmj.1.5645.663.
2
Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.保加利亚生产的吸附破伤风和白喉类毒素的效价控制
Prog Immunobiol Stand. 1970;4:548-52.
3
[Reactogenicity of adsorbed pertussis-diphtheria-tetanus vaccine with a parapertussi component].
Zh Mikrobiol Epidemiol Immunobiol. 1967 Oct;44(10):85-9.
4
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国，一项比较联合使用无细胞百白破、灭活脊髓灰质炎（DTaP-IPV）疫苗与分别单独使用百白破（DTaP）和脊髓灰质炎（IPV）疫苗的免疫原性和安全性的随机对照研究：在婴儿中进行的研究。
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
5
IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.给2至4月龄越南婴儿接种的全细胞百白破-乙肝- b型流感嗜血杆菌联合疫苗（Quinvaxem®）的免疫原性和安全性
Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):753-63.
6
New combined alum hydroxide adsorbed diphtheria-tetanus-pertussis-vaccine with parapertussis component. I. Reactogenicity and serological efficacy.新型含副百日咳成分的氢氧化铝吸附白喉-破伤风-百日咳联合疫苗。I. 反应原性和血清学效力。
J Hyg Epidemiol Microbiol Immunol. 1970;14(2):143-7.
7
Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.对13 - 14岁儿童同时接种卡介苗、白喉 - 破伤风疫苗和口服脊髓灰质炎疫苗。
Br Med J. 1971 Apr 24;2(5755):193-7. doi: 10.1136/bmj.2.5755.193.
8
Pertussis immunization of infants using a new combined DTP-polio vaccine.使用新型百白破-脊髓灰质炎联合疫苗对婴儿进行百日咳免疫接种。
Dev Biol Stand. 1985;61:309-13.
9
[The immunological basis of the administration of DTP-polio vaccine].[白百破-脊髓灰质炎疫苗接种的免疫学基础]
Verh K Acad Geneeskd Belg. 2000;62(4):245-67.
10
A comparison of combined diphtheria, tetanus and pertussis vaccines produced by different manufacturers, in laboratory animals and in infants.不同制造商生产的白喉、破伤风和百日咳联合疫苗在实验动物和婴儿中的比较。
J Biol Stand. 1986 Jul;14(3):241-7. doi: 10.1016/0092-1157(86)90009-0.
引用本文的文献
1
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations.疫苗佐剂的进展：从明矾到纳米制剂的历程
Vaccines (Basel). 2023 Nov 9;11(11):1704. doi: 10.3390/vaccines11111704.
2
Pharmaceutical and Immunological Evaluation of Cholera Toxin A1 Subunit as an Adjuvant of Hepatitis B Vaccine Microneedles.霍乱毒素 A1 亚单位作为乙肝疫苗微针佐剂的药物和免疫评估。
Pharm Res. 2023 Dec;40(12):3059-3071. doi: 10.1007/s11095-023-03623-9. Epub 2023 Nov 1.
3
Aluminium adjuvants versus placebo or no intervention in vaccine randomised clinical trials: a systematic review with meta-analysis and Trial Sequential Analysis.铝佐剂与安慰剂或疫苗随机临床试验中不干预的比较：系统评价与荟萃分析和试验序贯分析。
BMJ Open. 2022 Jun 23;12(6):e058795. doi: 10.1136/bmjopen-2021-058795.
4
Models and Assays for the Assessment of Pertussis Toxin Activity.用于评估百日咳毒素活性的模型和检测方法。
Toxins (Basel). 2021 Aug 12;13(8):565. doi: 10.3390/toxins13080565.
5
Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.带负电荷的碳纳米角负载阳离子脂质体纳米颗粒：一种用于抗尼古丁疫苗的新型递送载体。
J Biomed Nanotechnol. 2015 Dec;11(12):2197-210. doi: 10.1166/jbn.2015.2156.
6
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.疫苗佐剂的比较安全性：当前证据与未来需求综述
Drug Saf. 2015 Nov;38(11):1059-74. doi: 10.1007/s40264-015-0350-4.
7
Adjuvants and lymphoma risk as part of the ASIA spectrum.作为亚洲谱系一部分的佐剂与淋巴瘤风险
Immunol Res. 2015 Feb;61(1-2):79-89. doi: 10.1007/s12026-014-8622-0.
8
Mechanism of immunopotentiation and safety of aluminum adjuvants.铝佐剂的免疫增强机制与安全性。
Front Immunol. 2013 Jan 10;3:406. doi: 10.3389/fimmu.2012.00406. eCollection 2012.
9
Phytol-derived novel isoprenoid immunostimulants.植物衍生的新型类异戊二烯免疫刺激剂。
Front Immunol. 2012 Mar 22;3:49. doi: 10.3389/fimmu.2012.00049. eCollection 2012.
10
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.铝、氧化铝和氢氧化铝的人体健康风险评估。
J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. doi: 10.1080/10937400701597766.
本文引用的文献
1
Trial of Whooping-cough Vaccine.百日咳疫苗试验
Br Med J. 1945 Aug 18;2(4415):205-8. doi: 10.1136/bmj.2.4415.205.
2
Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.百日咳疫苗研究中的小鼠保护试验：采用脑内接种途径进行攻击的比较系列试验。
Am J Public Health Nations Health. 1947 Jul;37(7):803-10.
3
WHOOPING-COUGH: DIFFICULTIES IN DIAGNOSIS AND INEFFECTIVENESS OF IMMUNIZATION.百日咳：诊断难点与免疫接种的无效性
Br Med J. 1965 Sep 11;2(5462):623-6. doi: 10.1136/bmj.2.5462.623.
4
PERTUSSIS VACCINE TESTING FOR FREEDOM-FROM-TOXICITY.百日咳疫苗无毒性检测
Appl Microbiol. 1965 May;13(3):447-56. doi: 10.1128/am.13.3.447-456.1965.
5
EFFECTIVENESS OF PERTUSSIS VACCINES.百日咳疫苗的有效性。
Br Med J. 1965 Jul 3;2(5452):11-3. doi: 10.1136/bmj.2.5452.11.
6
Response of 3-months-old infants to 3 doses of trivalent oral poliomyelitis vaccine.3月龄婴儿对三价口服脊髓灰质炎疫苗3剂次的应答
Br Med J. 1963 Jun 15;1(5345):1573-4. doi: 10.1136/bmj.1.5345.1573.
7
Immunization of babies with diphtheriatetanus-pertusis prophylactic.用白喉-破伤风-百日咳预防性疫苗给婴儿接种。
Br Med J. 1955 Sep 10;2(4940):635-9. doi: 10.1136/bmj.2.4940.635.
8
Immune responses to diphtheria, tetanus, and pertussis, aluminum phosphate adsorbed.对白喉、破伤风和百日咳（吸附磷酸铝）的免疫反应。
Am J Public Health Nations Health. 1954 Jun;44(6):784-8. doi: 10.2105/ajph.44.6.784.
9
Vaccines against pertussis.百日咳疫苗
Public Health. 1967 Jul;81(5):252-64. doi: 10.1016/s0033-3506(67)80033-7.
Zotero 插件